Skip to main content

Nutrition Poor

0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
HazelnutsN/A1 trial
Active Trials
NCT03485989Completed41Est. Dec 2017
Agile Therapeutics
Agile TherapeuticsNJ - Princeton
1 program
Technology interventionN/A
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Technology interventionN/A1 trial
Active Trials
NCT05220631Active Not Recruiting369Est. Jan 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Human BioSciencesTechnology intervention
Oregon TherapeuticsHazelnuts

Clinical Trials (2)

Total enrollment: 410 patients across 2 trials

NCT05220631Human BioSciencesTechnology intervention

Digital Nutrition Intervention for Older Adults

Start: Jun 2022Est. completion: Jan 2026369 patients
N/AActive Not Recruiting

Role of Hazelnut Consumption in Improving Micronutrient Status in Older Adults

Start: Jun 2016Est. completion: Dec 201741 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.